Core Viewpoint - The company, Fujian Tianma Technology Group Co., Ltd., has announced the completion of tax payment and penalties totaling 5.3625 million yuan, following a self-inspection based on tax authority requirements [1]. Group 1: Basic Situation - The company and its subsidiaries are required to pay a total of 5.3625 million yuan in tax and late fees, which have been fully paid as of the announcement date [1]. - The tax payment does not involve any administrative penalties [1]. Group 2: Impact on the Company - According to relevant regulations, the tax payment and penalties do not constitute prior accounting errors and will not require adjustments to previous financial data [1]. - The payment will be recorded in the company's 2025 profit and loss statement, expected to reduce the net profit attributable to shareholders by 5.3625 million yuan for the year 2025, subject to final audited financial statements [1]. - This tax payment will not affect the company's normal operations [1].

我出生在福建泉州，从小在海边长大，对海洋有着深厚的感情，骨子里流淌着闽商"敢为人先、爱拼会 赢"的血液。作为中国特种水产业鳗鱼产业的见证者、参与者、推动者、收获者，我见证了行业"从无到 有，从小到大"的蜕变历程。从靠"一粒饲料走天下"起步，到现在我们以"鳗业为核心，食品为新蓝海， 饲料为主基石"产业战略定位，公司鳗鱼产业规模已跃居全球首位。 从早期定下"安全、高效、环保"作为产品属性到构建从种苗到餐桌的全流程可溯源体系，食品安全是我 们贯穿三十余年发展的核心命题。我们的产品因此畅销全球70多个国家和地区，今年我们也将活鳗出口 到韩国和日本，在日本设立分公司成立新品牌，深化了我们的全球化战略，现在中国的鳗鱼出口已经占 全球的70%。 自从天马科技（603668）上市后，我们就通过"实业+资本"的战略赋能产业发展，带动了渔民和农民的 增收，我们也将继续坚持"为了人类健康，追求卓越品质"的信念，牢牢紧扣安全、绿色、健康、美味的 产业属性，以新质产业化发展做精鳗鱼全产业链，打造世界级全产业链食品供应链平台，成为中国资本 市场乃至全球渔牧产业中一张闪亮的"价值名片"。 早期，我们国家的鳗鱼产业基础薄弱、材料不足、配套装 ...

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

证券代码：603668 证券简称：天马科技 公告编号：2025-095 福建天马科技集团股份有限公司 关于补缴税款的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 福建天马科技集团股份有限公司（以下简称"公司"）及合并报表范围内子 公司（以下简称"子公司"）近期根据税务部门的要求，对涉税事项展开自查， 现将有关情况公告如下： 一、基本情况 经自查，公司及子公司应补缴税款及滞纳金合计 536.25 万元。截至本公告 披露日，公司及子公司已按要求将上述税款及滞纳金缴纳完毕，本事项不涉及行 政处罚。 二、对公司的影响 特此公告。 福建天马科技集团股份有限公司 董 事 会 二〇二五年十二月十八日 根据《企业会计准则第 28 号——会计政策、会计估计变更和差错更正》相 关规定，上述补缴税款及滞纳金事项不属于前期会计差错，不涉及前期财务数据 追溯调整。本次补缴税款及滞纳金将计入公司 2025 年当期损益，预计将减少公 司 2025 年度归属于上市公司股东的净利润 536.25 万元，最终以 2025 年度经审 计的财务报表为准。本次 ...

格隆汇12月17日丨天马科技(603668.SH)公布，经自查，公司及子公司应补缴税款及滞纳金合计536.25万 元。截至本公告披露日，公司及子公司已按要求将上述税款及滞纳金缴纳完毕，本事项不涉及行政处 罚。 ...

Group 1 - The company reported a total eel output of approximately 1,197.15 tons for November 2025, with 219.85 tons for export and 977.30 tons for self-use [2] - The sales price range for eels in November 2025 was between 53,000 yuan/ton and 89,000 yuan/ton [2] - Cumulatively, from January to November 2025, the company produced approximately 16,415.87 tons of eels, with 8,698.67 tons for export and 7,717.20 tons for self-use [2] Group 2 - The eel output specifications primarily ranged from 1P to 5P [2] - The price fluctuations are attributed to the export of a small quantity of live Japanese eels to Japan and South Korea, which have different pricing compared to domestic sales [5] - The data provided is based on internal statistics and is unaudited, serving only as a reference for investors regarding the company's eel farming operations [6]

证券日报网讯12月12日晚间，天马科技（603668）发布2025年11月鳗鱼出池情况简报称，2025年11月， 公司鳗鱼出池约1，197.15吨，其中外销约219.85吨，自用约977.30吨，本月鳗鱼出池规格主要在1P~5P 之间，销售价格区间为5.3万元/吨~8.9万元/吨。2025年1月~11月，公司鳗鱼累计出池约16，415.87吨， 其中外销约8，698.67吨，自用约7，717.20吨，本期鳗鱼出池规格主要在1P~5P之间，销售价格区间为 5.0万元/吨~13.0万元/吨。 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

证券代码：603668 证券简称：天马科技 公告编号：2025-094 2025 年 1~11 月，公司鳗鱼累计出池约 16,415.87 吨，其中外销约 8,698.67 吨，自用约 7,717.20 吨，本期鳗鱼出池规格主要在 1P~5P 之间，销售价格区间 为 5.0 万元/吨~13.0 万元/吨。 说明：鳗鱼出池规格一般以每公斤的 P 数（尾数）为区分。 上述出池数据未经审计，与定期报告披露的数据之间可能存在差异，因此上 述数据仅作为阶段性数据供投资者参考。 | | 月份 | | 出池量（吨） | 外销数量（吨） | 自用数量（吨） | 销售价格区间 （万元/吨） | | --- | --- | --- | --- | --- | --- | --- | | 2025 | 年 1 | 月 | 902.15 | 627.70 | 274.45 | 5.2~7.7 | | 2025 | 年 2 | 月 | 1,012.28 | 730.12 | 282.16 | 5.0~8.7 | | 2025 | 年 3 | 月 | 1,295.83 | 583.05 | 712.78 | 5.0~8.7 | | 20 ...